05/10/2024
7:53 AM | Verona Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/10/2024
8:09 AM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:22 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:18 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
6:19 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:21 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:23 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/30/2024
3:15 PM | Brady James Aloysius (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:16 PM | Cunningham Kenneth (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | SHAH MAHENDRA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | Ullman Anders (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:17 PM | Edwards Martin (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2024
3:18 PM | Sinha Vikas (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:15 PM | Fisher Andrew (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
7:47 AM | Verona Pharma (Filer)
| Form ARS | |
03/20/2024
7:46 AM | Verona Pharma (Filer)
| Form DEF 14A | |
03/12/2024
6:45 PM | Gupta Rishi (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/08/2024
3:18 PM | Verona Pharma (Filer)
| Form PRE 14A | |
03/07/2024
8:40 PM | Fisher Andrew (Reporting)
Verona Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/04/2024
7:15 PM | ORBIMED ADVISORS LLC (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
8:00 AM | Verona Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
5:08 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2024
5:09 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:10 PM | Poll Claire (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:11 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:11 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
5:02 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
5:05 AM | Austwick Michael (Reporting)
Verona Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/02/2024
5:07 AM | Austwick Michael (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
5:02 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
3:15 PM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2023
4:09 PM | Edwards Martin (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
3:15 PM | EBSWORTH DAVID R (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
7:08 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
7:09 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
7:09 PM | Poll Claire (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
7:11 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:25 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
3:16 PM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad) Learn more about why Zack’s has increased its price target on this company to a whopping $23.25! Click for Zack's full report |
11/02/2023
5:24 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2023
3:06 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
3:06 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
5:02 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2023
3:05 PM | ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/05/2023
3:05 PM | ACKERMANN CHRISTINA (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
8:15 PM | Poll Claire (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
8:17 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
8:17 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
8:19 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
7:31 PM | Hahn Mark W (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
7:27 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
7:29 PM | Verona Pharma (Issuer)
ZACCARDELLI DAVID (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
7:30 PM | Poll Claire (Reporting)
Verona Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
3:12 PM | Rickard Kathleen A. (Reporting)
Verona Pharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023
7:34 AM | Verona Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
5:11 AM | Verona Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
